NCT02747511View on ClinicalTrials.gov

IV Haloperidol for the Treatment of Headache in the ED

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
HeadacheMigraine Disorders
Interventions
DRUG

Haloperidol

DRUG

Placebo

All Listed Sponsors
lead

Western Michigan University School of Medicine

OTHER

NCT02747511 - IV Haloperidol for the Treatment of Headache in the ED | Biotech Hunter | Biotech Hunter